Skip to main content

Kymera Therapeutics, Inc.

KYMR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001815442

In the last 90 days, Kymera Therapeutics, Inc. insiders filed 0 open-market purchases and 2 sales; 276 institutions reported holding it in 13F filings for Q2 2026, worth $11.1B in total; no superinvestor holds it.

13F holders, Q4 2023

Institutional positions in Kymera Therapeutics, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
137
+15 vs. Q3 2023
Shares held
60.5M
+3.11M (+5.4%) vs. Q3 2023
Total value
$1.54B
+$742.1M (+93.1%) vs. Q3 2023
New holders
33
36 more added
Sold out
18
53 more reduced

Compare with Q3 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting KYMR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2023: 137 institutions
Q1 2021: 97 institutionsQ2 2021: 110 institutionsQ3 2021: 115 institutionsQ4 2021: 128 institutionsQ1 2022: 126 institutionsQ2 2022: 101 institutionsQ3 2022: 128 institutionsQ4 2022: 121 institutionsQ1 2023: 127 institutionsQ2 2023: 129 institutionsQ3 2023: 122 institutionsQ4 2023: 137 institutionsQ1 2024: 164 institutionsQ2 2024: 157 institutionsQ3 2024: 176 institutionsQ4 2024: 181 institutionsQ1 2025: 174 institutionsQ2 2025: 210 institutionsQ3 2025: 210 institutionsQ4 2025: 255 institutionsQ1 2026: 256 institutionsQ2 2026: 276 institutions
Value heldQ4 2023: $1.54B
Q1 2021: $887.2MQ2 2021: $1.29BQ3 2021: $2.04BQ4 2021: $2.76BQ1 2022: $1.93BQ2 2022: $973.6MQ3 2022: $1.15BQ4 2022: $1.40BQ1 2023: $1.68BQ2 2023: $1.34BQ3 2023: $797.2MQ4 2023: $1.54BQ1 2024: $2.70BQ2 2024: $2.01BQ3 2024: $3.27BQ4 2024: $2.89BQ1 2025: $2.00BQ2 2025: $3.44BQ3 2025: $4.58BQ4 2025: $6.99BQ1 2026: $8.01BQ2 2026: $11.1B
Institutions holding KYMR and their total value by quarter
QuarterHoldersValue
Q2 2026276$11.1B
Q1 2026256$8.01B
Q4 2025255$6.99B
Q3 2025210$4.58B
Q2 2025210$3.44B
Q1 2025174$2.00B
Q4 2024181$2.89B
Q3 2024176$3.27B
Q2 2024157$2.01B
Q1 2024164$2.70B
Q4 2023137$1.54B
Q3 2023122$797.2M
Q2 2023129$1.34B
Q1 2023127$1.68B
Q4 2022121$1.40B
Q3 2022128$1.15B
Q2 2022101$973.6M
Q1 2022126$1.93B
Q4 2021128$2.76B
Q3 2021115$2.04B
Q2 2021110$1.29B
Q1 202197$887.2M

Institutions, Q4 2023

Shares, value and share of portfolio for each institution holding Kymera Therapeutics, Inc.; share changes are against Q3 2023.

Institutions holding KYMR in Q4 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Two Sigma Advisers, LP170,900$4.35M0.01%−17,600−9.3%Reduced
UBS Asset Management Americas Inc176,500$4.49M0.00%−13,233−7.0%Reduced
Schroder Investment Management Group185,299$4.72M0.01%−42,281−18.6%Reduced
TD Asset Management Inc186,482$4.75M0.00%+2,400+1.3%Added
Jane Street Group, LLC195,967$4.99M0.01%+96,915+97.8%Added
Trexquant Investment LP203,564$5.18M0.12%+203,564New
Voloridge Investment Management, LLC241,798$6.16M0.02%+114,983+90.7%Added
UBS Group AG300,463$7.65M0.00%+137,704+84.6%Added
Charles Schwab Investment Management Inc306,692$7.81M0.00%+4,951+1.6%Added
Candriam Luxembourg S.C.A.343,302$8.74M0.06%−145,004−29.7%Reduced
Northern Trust Corp358,579$9.13M0.00%−7,676−2.1%Reduced
Citadel Advisors LLC371,443$9.46M0.01%+152,460+69.6%Added
Barclays PLC381,781$9.72M0.01%−7,695−2.0%Reduced
Schonfeld Strategic Advisors LLC437,633$11.1M0.09%+437,633New
Morgan Stanley441,278$11.2M0.00%+101,950+30.0%Added
Massachusetts Financial Services Co462,675$11.8M0.00%−858−0.2%Reduced
Norges Bank504,083$12.8M0.00%+386,200+327.6%Added
JPMorgan Chase & Co512,246$13.0M0.00%−109,746−17.6%Reduced
Dimensional Fund Advisors LP533,723$13.6M0.00%−121,504−18.5%Reduced
FMR LLC534,600$13.6M0.00%−335,947−38.6%Reduced
Deer Management Co. LLC615,895$15.7M2.03%00.0%Unchanged
Goldman Sachs Group Inc674,655$17.2M0.00%+469,947+229.6%Added
Geode Capital Management, LLC880,515$22.4M0.00%+46,288+5.5%Added
Aquilo Capital Management, LLC881,337$22.4M15.74%+99,118+12.7%Added
T. Rowe Price Investment Management, Inc.1,295,943$33.0M0.02%−314,553−19.5%Reduced
Rock Springs Capital Management LP1,522,238$38.8M0.96%+17,887+1.2%Added
Redmile Group, LLC1,823,956$46.4M1.66%−44,551−2.4%Reduced
State Street Corp1,894,279$48.2M0.00%−91,607−4.6%Reduced
Artal Group S.A.2,530,735$64.4M2.20%+725,389+40.2%Added
BlackRock Inc.3,566,611$90.8M0.00%+208,727+6.2%Added
Avoro Capital Advisors LLC3,775,000$96.1M1.33%−80,000−2.1%Reduced
Vanguard Group Inc3,997,564$101.8M0.00%+72,351+1.8%Added
Wellington Management Group LLP4,815,558$122.6M0.02%−7,771−0.2%Reduced
BVF Inc5,161,801$131.4M3.29%+422,797+8.9%Added
Price T Rowe Associates Inc5,335,712$135.8M0.02%+278,287+5.5%Added
Atlas Venture Life Science Advisors, LLC5,858,262$149.2M17.76%00.0%Unchanged
Baker Bros. Advisors LP5,995,928$152.7M1.74%+1,245,528+26.2%Added
Wasatch Advisors Inc0$00.00%−572,907−100.0%Sold out
Gilder Gagnon Howe & Co LLC0$00.00%−81,865−100.0%Sold out
Point72 Asset Management, L.P.0$00.00%−81,400−100.0%Sold out
Marshall Wace, LLP0$00.00%−54,837−100.0%Sold out
Qube Research & Technologies Ltd0$00.00%−50,785−100.0%Sold out
Dark Forest Capital Management LP0$00.00%−36,698−100.0%Sold out
Tudor Investment Corp Et Al0$00.00%−27,296−100.0%Sold out
Raymond James & Associates0$00.00%−26,297−100.0%Sold out
Y-Intercept (Hong Kong) Ltd0$00.00%−25,476−100.0%Sold out
Allianz Asset Management GmbH0$00.00%−13,200−100.0%Sold out
Aquatic Capital Management LLC0$00.00%−12,200−100.0%Sold out
Dynamic Technology Lab Private Ltd0$00.00%−11,359−100.0%Sold out
ExodusPoint Capital Management, LP0$00.00%−11,217−100.0%Sold out
Handelsbanken Fonder AB0$00.00%−10,600−100.0%Sold out
Public Employees Retirement System of Ohio0$00.00%−8,301−100.0%Sold out
Allspring Global Investments Holdings, LLC0$00.00%−5,183−100.0%Sold out
Amundi0$00.00%−1,642−100.0%Sold out
Advisor Group Holdings, Inc.0$00.00%−300−100.0%Sold out